Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06338878
Other study ID # 2023PI087
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2024
Est. completion date January 2029

Study information

Verified date February 2024
Source Central Hospital, Nancy, France
Contact Laura FILIPPETI
Phone 0383157322
Email l.filippetti@chru-nancy.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a monocentric cohort study conducted in the cardiology department of Nancy hospital. The main purpose of the study is to document the global management strategy of patients hospitalized for heart failure and evaluate the association between patient's care and post-hospitalization outcome.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date January 2029
Est. primary completion date January 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Man or women = 18 years - Patients hospitalized for cardiac decompensation (ESC 2016 and 2021 criteria) Exclusion Criteria: - Patient expressing refusal to participate in research - Patient who is a minor or under administrative protection - Pregnant women - Patient with ventricular assistance - Patient with congenital heart disease

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France CHRU de Nancy Nancy

Sponsors (1)

Lead Sponsor Collaborator
Pr. Nicolas GIRERD

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary All-cause post-hospitalization mortality Composite endpoint of all-cause post-hospitalization mortality and rehospitalization for heart failure with outcome 2 Within 1 year following hospital discharge
Primary Rehospitalization for heart failure Composite endpoint of all-cause post-hospitalization mortality and rehospitalization for heart failure with outcome 1 Within 1 year following hospital discharge
Secondary Percentage of maximum dose of each cardiotropic treatment indicated in heart failure according to ESC recommendations Within 1 year following hospital discharge
Secondary Influenza and pneumococcal vaccination status Within 1 year following hospital discharge
Secondary Evolution of renal function Note: assessed by creatinine levels and GFR by CKD EPI During hospitalization for up to 2 months and within 1 year after discharge.
Secondary All-cause Rehospitalization Assessed by: Rehospitalization for any cause other than hear failure after discharge. Within 1 year following hospital discharge
Secondary All-cause mortality Within 1 year following hospital discharge
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy